Share this article
SALT LAKE CITY, Feb. 16, 2021 /PRNewswire/ Co-Diagnostics, Inc.
(Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will be presenting on direct saliva testing for COVID-19 at the 28
th Annual International Molecular Medicine Tri-Conference, held virtually on February 16-18, 2021.
Company representatives will introduce the Co-Diagnostics Logix Smart SARS-CoV-2 DS (Direct Saliva) kit, which the Company has submitted for Emergency Use Authorization (EUA) to the US Food and Drug Administration (FDA). The virtual presentation will be webcast to conference attendees at 4:30 pm EST on Tuesday February 16
Co-Diagnostics Inc to present on direct saliva testing at Molecular Medicine Tri-Conference proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.